ARCHIVES

Lasofoxifene Reduced Breast Cancer Risk In Postmenopausal Osteoporotic Women

This article is from The Cancer Letter archive.

Vol. 33 No. 11 | November 26, 2010

Download PDF Visit The Full Archive

Related Articles

NCAB Wants NCI To Avoid Setting Guidelines Regarding Health Policy

March 4, 1994

Funding opportunities listed.

June 25, 2004

Women’s Health Initiative Trial Produced $37.1 Billion in Returns

May 9, 2014

Consensus Conference Planned On Adjuvant Chemotherapy For Breast Cancer

March 22, 1985

In Brief: House Money Bill Reportedly Will Not Increase

September 18, 1981

The Cancer Letter Wins Awards (12-page issue).

June 13, 2003